Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On October 21, 2025, the Company issued a press release titled "MediBeacon receives regulatory approval to sell the Transdermal GFR System in Chin
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated October 21, 2025, titled “MediBeacon receives regulatory approv